- Net income more than doubled to 311 million (2005: 144m) - Dividend of 2.00 per share proposed, plus a special bonus of 0.50 - Sales grew 21 percent to 3.34 billion (2005: 2.76bn) - In 2007 focus on capacity expansion and continued growth in sales and earnings ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. balance Munich (euro adhoc) - ...
Tip announcement for financial statements transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The financial statement is available: in the internet at: http://www.wacker.com/cms/en/investor-relations/berichte/quarterly-2007-1/quartalsbericht-2007-1.jsp in the internet on: 08.05.2007 additional statements: On May. 8, 2007 at about 8:30 A.M. CET you can download the quarterly ...
- SALES UP 21 PERCENT TO 3.33 BILLION - EBITDA INCREASED TO 785 MILLION - BEST YEAR IN WACKER GROUPS HISTORY ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Munich (euro adhoc) - February 15, 2007 - According to its preliminary business results for fiscal 2006, Wacker Chemie AG saw a record year ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Zhangjiagang (China) (euro adhoc) - February 8, 2007 - Today, WACKER celebrated the Grand Opening of its new silicone downstream facilities at Jiangsu Yangtze River Chemical Industrial Park in Zhangjiagang City, Jiangsu Province. The facilities consist of two production plants for silicone elastomers and for ...
Ingelheim, Germany (ots/PRNewswire) - Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a protease inhibitor-based regimen to a non-nucleoside reverse transcriptase inhibitor-based regimen containing Viramune(R) (nevirapine) or efavirenz achieved comparable efficacy and safety to their previous regimen ...
Joint press release of WACKER and TU München - NEW INSTITUTE, UNDER THE DIRECTION OF THE WACKER CHAIR OF MACROMOLECULAR CHEMISTRY, ESTABLISHED WITHIN THE FACULTY OF CHEMISTRY - FUNDING TO TOTAL SIX MILLION EUROS - CEO PETER-ALEXANDER WACKER: THE INSTITUTE UNDERSCORES THE ECONOMIC IMPORTANCE OF SILICONE CHEMISTRY AND STRENGTHENS GERMANYS POSITION AS A RESEARCH ...
Glasgow, Scotland, November 15 (ots/PRNewswire) - - New Sub-analyses Provide Insight into Treatment Benefits New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with ritonavir (tipranavir/r) as part of combination antiretroviral therapy, continued to ...
Ingelheim, Germany, November 10 (ots/PRNewswire) - - Millions of People Worldwide Living With RLS to Benefit as Treatment Becomes Globally Available Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the ...
- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (EBITDA) REACH 217.9 MILLION - EBITDA MARGIN AT 25.4 PERCENT - GROUP SALES CLIMB TO 857.3 MILLION - EARNINGS PER SHARE RISE TO 1.91 - FULL-YEAR 2006 SALES AND EARNINGS FORECAST CONFIRMED ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. München (euro adhoc) - In Q3 2006, Wacker Chemie ...
Kyoto, Japan (ots/PRNewswire) - - Further Therapeutic Potential of Pramipexole to be Investigated in New Disease-Modification Trial - For non-US Healthcare Media New data presented today from a meta-analysis* of nearly 1,300 Parkinson's disease (PD) patients indicate that pramipexole (Mirapexin(R) ...
Berlin, Germany (ots/PRNewswire) - - Global Survey Highlights Misunderstandings About Causes and Treatment of Constipation - Not for use or publication in the USA Many people with constipation are confused about the cause of their condition and its appropriate treatment with laxatives. Results of a new large-scale global survey, announced today, show ...
ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Construction of Chinas largest siloxane facility officially began following the groundbreaking ceremony today at the site in Zhangjiagang, China. Representatives from Dow Corning Corporation (Midland, Michigan, USA) and Wacker Chemie AG (Munich, ...
- EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (EBITDA) TOTAL 195.7 MILLION - EBITDA MARGIN OF 24 PERCENT - AT 830.4 MILLION, GROUP SALES RISE 18 PERCENT YEAR ON YEAR - EARNINGS PER SHARE MORE THAN DOUBLED TO 1.35 - STRONG DEMAND AND HIGHER PRICES FOR SILICON WAFERS RAISE WACKERS EARNINGS ESTIMATES ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of ...
Toronto (ots/PRNewswire) - New data on tipranavir oral solution from a Phase II dose finding study in 115 HIV-1 infected children aged 2 to 18 years were announced today at the 16th International AIDS Conference (IAC) in Toronto, Canada. Results from this 48-week analysis show that patients achieved virologic ...
ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Dow Corning Corporation (Midland, Michigan, USA) and Wacker Chemie AG (Munich, Germany) announce that their manufacturing joint venture company Dow Corning (Zhangjiagang) Co, Ltd. received official approval from the Chinese government to jointly build a ...
ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Reflecting ongoing favorable trading conditions and further improved expectations regarding customer demand for semiconductor wafers for the second half of 2006, WACKER is raising its full-year sales and earnings forecast. The chemical company based in ...
Equal contributions USD 1 billion investment Start of production planned for mid 2008 Design capacity of 300,000 wafers per month ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Semiconductor technology leader Samsung Electronics Co., Ltd., the world leader in advanced semiconductor ...
- DECISION TO EXPAND NOMINAL PRODUCTION CAPACITY BY ANOTHER 4,500 METRIC TONS PER YEAR - SOLAR-SECTOR DEMAND FOR POLYSILICON EXPECTED TO SHOW FURTHER RAPID GROWTH - CAPITAL EXPENDITURES OF ABOUT 300 MILLION ARE ESTIMATED TO CREATE SOME 270 JOBS - CEO PETER-ALEXANDER WACKER: WEVE REACHED ANOTHER MILESTONE IN OUR GROUPS LONG-TERM STRATEGY FOR PROFITABLE ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 28.06.2006 Munich / Burghausen, June 28, 2006 - Wacker Chemie AG plans to expand its polysilicon production in Burghausen by 4,500 metric tons per year to a total of 14,500 metric tons by the ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF CEO Hambrecht: 'We started the integration process.' BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the successful completion of its acquisition of Engelhard Corporation (NYSE: EC). "Together with the Engelhard team we have started the integration process in which our customers continue to be the key priority," ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF Announces Completion of Subsequent Offering Period BASF Aktiengesellschaft (Frankfurt: BAS; NYSE: BF [ADR]; LSE: BFA; SWX: AN) today announced the completion of the subsequent offering period for the outstanding shares of Engelhard. As of 8:00 p.m. New York City time on June 8, 2006, a total of 113,489,680 shares, representing more than 90% of Engelhard's (NYSE: ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF-CEO Hambrecht: 'Special day for BASF and Engelhard, more innovative solutions for customers.' - Subsequent offering period to expire on June 8, 2006 BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the expiration of its initial tender offer period to purchase all of the outstanding shares of Engelhard Corporation ...
Ludwigshafen, Germany (ots/PRNewswire) - - Engelhard Recommends That Engelhard's Shareholders Accept BASF's Offer - BASF CEO Hambrecht: "Crucial step towards acquisition of Engelhard." BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) announced today that it signed a definitive agreement with Engelhard Corporation (NYSE: EC). According to the agreement, Engelhard will recommend that Engelhard shareholders tender their shares to BASF ...
Ludwigshafen, Germany (ots/PRNewswire) - BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced that Institutional Shareholder Services (ISS) has recommended that Engelhard's shareholders vote for BASF's five nominees for election to Engelhard's Board of Directors at the June 2 Annual Shareholders' Meeting. ISS is a ...
Ingelheim, Germany (ots/PRNewswire) - - Not for Distribution or Publication in the United States New omnibus data from the largest global survey due to be published, conducted on the epidemiology of constipation, were presented today at the Digestive Disease Week congress in Los Angeles. The survey, sponsored by Boehringer Ingelheim, offers new insights into the incidence of constipation and shows that ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF CEO Hambrecht: 'This is our last, best and final offer.' BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced that it has raised its all-cash offer for Engelhard Corporation (NYSE: EC) to US$39 per share from its previous offer of US$38 per share. "We are confident that Engelhard's shareholders will recognize the superior ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Professional and Consumer Journalists - Not for Distribution to USA Media - Survey Shows 25% of World's Population Suffer From Common and Distressing Ailment That can be Effectively Treated New data presented at the premier international gastroenterology congress Digestive Disease Week (DDW) 2006 ...
ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WACKER, the Munich-based chemical company, is constructing a new plant to expand its production capacity for dispersible polymer powders by another 30,000 metric tons per year. Designed to offer world-class technology and capacity levels, the new plant ...
- EBITDA DOUBLES TO 183.6 MILLION - GROUP SALES RISE TO 798.5 MILLION, 190 MILLION ABOVE PRIOR-YEAR - EARNINGS PER SHARE CLIMB STRONGLY TO 1.49 - FOR 2006, SALES GROWTH ABOVE 10 PERCENT AND EBITDA BETWEEN 640 MILLION AND 680 MILLION EXPECTED ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Wacker Chemie AG reports a year-on-year sales growth ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 16.05.2006 Munich, May 16, 2006 - Wacker Chemie AG reported strong year-on-year sales growth and even stronger earnings for Q1 2006. Consolidated sales rose to EUR798.5 million (Q1 2005: ...
